Liming Lin

1.2k total citations
73 papers, 842 citations indexed

About

Liming Lin is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Liming Lin has authored 73 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 25 papers in Molecular Biology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Liming Lin's work include Cardiovascular Health and Risk Factors (6 papers), Blood Pressure and Hypertension Studies (6 papers) and Antimicrobial Peptides and Activities (5 papers). Liming Lin is often cited by papers focused on Cardiovascular Health and Risk Factors (6 papers), Blood Pressure and Hypertension Studies (6 papers) and Antimicrobial Peptides and Activities (5 papers). Liming Lin collaborates with scholars based in China, United States and Türkiye. Liming Lin's co-authors include Chao Lü, Guilan Quan, Chuanbin Wu, Rui Luo, Dongyi Xian, Jinxiu Lin, Meifang Wu, Xin Pan, Xiaoqian Feng and Changsheng Xu and has published in prestigious journals such as Nature Communications, Bioresource Technology and Scientific Reports.

In The Last Decade

Liming Lin

62 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liming Lin China 16 257 151 108 105 103 73 842
Valerie A. Schroeder United States 22 634 2.5× 93 0.6× 113 1.0× 72 0.7× 110 1.1× 45 1.7k
Maura Di Vito Italy 20 501 1.9× 67 0.4× 104 1.0× 25 0.2× 69 0.7× 63 1.3k
Tomasz Wollny Poland 15 316 1.2× 37 0.2× 138 1.3× 142 1.4× 42 0.4× 33 842
Yi‐Yin Chen China 17 441 1.7× 47 0.3× 66 0.6× 72 0.7× 50 0.5× 42 1.0k
Qi Xu China 20 389 1.5× 200 1.3× 44 0.4× 30 0.3× 82 0.8× 60 1.2k
Yongxiang Wang China 23 700 2.7× 40 0.3× 89 0.8× 59 0.6× 269 2.6× 85 1.5k
Xiaoyu Yang China 18 462 1.8× 49 0.3× 51 0.5× 45 0.4× 262 2.5× 72 1.2k
Young–Jin Choi South Korea 19 329 1.3× 196 1.3× 76 0.7× 11 0.1× 252 2.4× 72 1.3k
Prince Allawadhi India 19 470 1.8× 42 0.3× 197 1.8× 17 0.2× 101 1.0× 26 1.2k

Countries citing papers authored by Liming Lin

Since Specialization
Citations

This map shows the geographic impact of Liming Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liming Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liming Lin more than expected).

Fields of papers citing papers by Liming Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liming Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liming Lin. The network helps show where Liming Lin may publish in the future.

Co-authorship network of co-authors of Liming Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Liming Lin. A scholar is included among the top collaborators of Liming Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liming Lin. Liming Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Jibo, Liming Lin, Lintao Wang, et al.. (2025). Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male mice. Nature Communications. 16(1). 5927–5927. 1 indexed citations
2.
Yang, Shuang, et al.. (2025). Protective effects of quercetin on LPS-induced liver injury in quails. Toxicon. 265. 108496–108496.
3.
Lin, Liming, Jibo Han, Bozhi Ye, et al.. (2025). Deubiquitinase USP13 alleviates doxorubicin-induced cardiotoxicity through promoting the autophagy-mediated degradation of STING. Acta Pharmaceutica Sinica B. 15(5). 2545–2558. 1 indexed citations
4.
Xian, Dongyi, Rui Luo, Liqing Wang, et al.. (2025). Epsilon-polylysine microneedle potentiating MXene-mediated photothermal ablation for combating antibiotic-resistant bacterial infections. Materials Today Bio. 31. 101498–101498. 2 indexed citations
5.
Chen, Wen, et al.. (2025). Vericiguat Improves Cardiac Remodelling and Function in Rats with Doxorubicin-Induced Cardiomyopathy. ESC Heart Failure. 12(3). 1807–1817. 2 indexed citations
6.
7.
Lin, Liming, et al.. (2024). The effect of postharvest water migration on metabolism of cassava root by hypobaric storage. Innovative Food Science & Emerging Technologies. 93. 103609–103609. 1 indexed citations
8.
Zhao, Ying‐Yong, Shijie Fan, Hong Zhu, et al.. (2024). Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury. Nature Communications. 15(1). 5441–5441. 17 indexed citations
9.
Ye, Bozhi, Liming Lin, Yuchen Jiang, et al.. (2024). Carnosol attenuates angiotensin II-induced cardiac remodeling and inflammation via directly binding to p38 and inhibiting p38 activation. International Immunopharmacology. 134. 112143–112143. 3 indexed citations
10.
11.
Xu, Jianjiang, et al.. (2024). Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytes. Cell Communication and Signaling. 22(1). 593–593. 4 indexed citations
12.
13.
Han, Xue, Weixin Li, Wu Luo, et al.. (2023). Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses. EMBO Molecular Medicine. 15(5). e17198–e17198. 31 indexed citations
14.
Lin, Liming, et al.. (2023). Tussilagone attenuates atherosclerosis through inhibiting MAPKs-mediated inflammation in macrophages. International Immunopharmacology. 119. 110066–110066. 4 indexed citations
15.
Wu, Min, et al.. (2019). Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives. Cardiovascular Drugs and Therapy. 33(6). 739–748. 31 indexed citations
16.
Xing, Aijun, et al.. (2015). [Relationship between ideal cardiovascular behaviors/factors and the prevalence of nonalcoholic fatty liver disease].. PubMed. 36(1). 40–4. 2 indexed citations
17.
Lin, Liming, et al.. (2006). The effect of storage of 2 varieties of golden algaes at different temperatures. Haiyang kexue. 1 indexed citations
18.
Lin, Liming, et al.. (2003). Agrobacterium-mediated transformation of NS6 gene of Rice grassy stunt virus. Journal of Fujian Agriculture and Forestry University. 32(3). 288–291. 2 indexed citations
19.
Lin, Liming, et al.. (2002). Advances in research on disease-specific protein of Tenuiviruses. Fujian nongye xuebao. 17(1). 26–28. 1 indexed citations
20.
Lin, Liming, et al.. (1991). Simultaneous determination of toxic metabolites by linear combination derivative spectrophotometry. The Analyst. 116(9). 919–919. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie A. Schroeder Breakdown of academic impact, for papers by Maura Di Vito Breakdown of academic impact, for papers by Tomasz Wollny Breakdown of academic impact, for papers by Yi‐Yin Chen Breakdown of academic impact, for papers by Qi Xu Breakdown of academic impact, for papers by Yongxiang Wang Breakdown of academic impact, for papers by Xiaoyu Yang Breakdown of academic impact, for papers by Young–Jin Choi Breakdown of academic impact, for papers by Prince Allawadhi
Rankless by CCL
2026